Katherine S. Zanotti - Jun 8, 2023 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
Director
Signature
/s/ Katherine S. Zanotti by Mark R. Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Jun 8, 2023
Transactions value $
-$273,974
Form type
4
Date filed
6/12/2023, 04:17 PM
Previous filing
Jul 28, 2022
Next filing
Jul 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Award $0 +3.6K +5.62% $0.00 67.7K Jun 8, 2023 Direct F1
transaction EXAS Common Stock Sale -$274K -3.03K -4.47% $90.51 64.6K Jun 9, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy.
F2 The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into on November 18, 2022.